GlassScriptPhysician profile
Martin L Smith
NPI 1588763338
$1,646.35
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $205 · 2021: $246 · 2022: $219 · 2023: $406 · 2024: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $707.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $697.94 | 2022-2024 | |
| Smith+Nephew, INC. | $391.99 | 2020-2024 | Grafix, Collagenase Santyl |
| Crossroads Extremity Systems, LLC | $121.95 | 2019 | |
| Rikco International, LLC | $117.99 | 2019 | |
| Tactile Systems Technology INC | $67.84 | 2019-2021 | |
| Stryker Corporation | $38.45 | 2024 | Actishield, Dart-Fire |
| Ethicon US, LLC | $34.72 | 2021 | |
| Grt US Holding, INC. | $33.00 | 2021 | |
| Paragon 28, INC. | $32.32 | 2023 | Joust Beaming |
| Kci USA, INC. | $32.24 | 2019-2023 | Activ.A.C. |
| Kerecis Limited | $23.68 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Horizon Therapeutics Plc | $21.61 | 2020 | |
| Celularity INC. | $16.87 | 2020 | |
| Orthofix Medical, INC. | $15.75 | 2024 | Accelstim, Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.